This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wullaert, A. Articles by Beyaert, R. Search for Related Content PubMed PubMed Citation Articles by Wullaert, A. Articles by Beyaert, R.

Hepatic Tumor Necrosis Factor Signaling and Nuclear Factor-B: Effects on Liver Homeostasis and Beyond

Unit of Molecular Signal Transduction in Inflammation, Department for Molecular Biomedical Research-VIB, and Department of Molecular Biology, Ghent University, Technologiepark 927, B-9052 Ghent (Zwijnaarde), Belgium

Correspondence: Address all correspondence and requests for reprints to: Rudi Beyaert, Department for Molecular Biomedical Research, VIB, Ghent University, Technologiepark 927, B-9052 Ghent (Zwijnaarde), Belgium. E-mail: rudi.beyaert{at}dmbr.ugent.be

The proinflammatory cytokine TNF has a pivotal role in liver pathophysiology because it holds the capacity to induce both hepatocyte cell death and hepatocyte proliferation. This dual effect of TNF on hepatocytes reflects its ability to induce both nuclear factor B (NF-B)-dependent gene expression and cell death. Multiple studies have demonstrated the crucial role of the transcription factor NF-B in the decision between life and death of a hepatocyte. Massive hepatocyte apoptosis preceding embryonic lethality in NF-B-deficient mice constituted the first indication of an essential antiapoptotic function of NF-B in the liver. Although many studies confirmed this crucial cytoprotective role of NF-B in adult liver, a number of genetic studies recently obtained conflicting results on the exact role of NF-B in different mouse models of TNF hepatotoxicity, demonstrating that caution should be taken when interpreting studies using different NF-B-deficient mice in distinct models of liver injury. Recent reports showing a role for hepatic NF-B activation in the proliferation of malignant cells during hepatocarcinogenesis, and in the progression of fatty liver diseases to insulin resistance and type 2 diabetes mellitus demonstrate that NF-B can also have more detrimental effects in the liver. Moreover, its role in the development of the metabolic syndrome emphasizes that hepatic NF-B activation might also have adverse effects on the endocrine system. Therefore, understanding the regulation of hepatic TNF signaling and NF-B activation is of critical therapeutic importance. In this review, we summarize how studies on the role of NF-B in different mouse models of liver pathologies have contributed to this understanding.

This article has been cited by other articles:

				D. Wei, J. Li, M. Shen, W. Jia, N. Chen, T. Chen, D. Su, H. Tian, S. Zheng, Y. Dai, et al. Cellular Production of n-3 PUFAs and Reduction of n-6-to-n-3 Ratios in the Pancreatic {beta}-Cells and Islets Enhance Insulin Secretion and Confer Protection Against Cytokine-Induced Cell Death Diabetes, February 1, 2010; 59(2): 471 - 478. [Abstract] [Full Text] [PDF]

				H. Song, K. K. Mak, L. Topol, K. Yun, J. Hu, L. Garrett, Y. Chen, O. Park, J. Chang, R. M. Simpson, et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression PNAS, January 26, 2010; 107(4): 1431 - 1436. [Abstract] [Full Text] [PDF]

				H.-Y. Liu, S. Y. Cao, T. Hong, J. Han, Z. Liu, and W. Cao Insulin Is a Stronger Inducer of Insulin Resistance than Hyperglycemia in Mice with Type 1 Diabetes Mellitus (T1DM) J. Biol. Chem., October 2, 2009; 284(40): 27090 - 27100. [Abstract] [Full Text] [PDF]

				W. Zou, K. M. Beggs, E. M. Sparkenbaugh, A. D. Jones, H. S. Younis, R. A. Roth, and P. E. Ganey Sulindac Metabolism and Synergy with Tumor Necrosis Factor-{alpha} in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 114 - 121. [Abstract] [Full Text] [PDF]

				H.-Y. Liu, T. Hong, G.-B. Wen, J. Han, D. Zuo, Z. Liu, and W. Cao Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E898 - E906. [Abstract] [Full Text] [PDF]

				S. E.-M. Peychal, A. Bilger, H. C. Pitot, and N. R. Drinkwater Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17 Carcinogenesis, May 1, 2009; 30(5): 879 - 885. [Abstract] [Full Text] [PDF]

				F. Haimerl, A. Erhardt, G. Sass, and G. Tiegs Down-regulation of the De-ubiquitinating Enzyme Ubiquitin-specific Protease 2 Contributes to Tumor Necrosis Factor-{alpha}-induced Hepatocyte Survival J. Biol. Chem., January 2, 2009; 284(1): 495 - 504. [Abstract] [Full Text] [PDF]

				D. D. Harrison-Findik, E. Klein, J. Evans, and J. Gollan Regulation of liver hepcidin expression by alcohol in vivo does not involve Kupffer cell activation or TNF-{alpha} signaling Am J Physiol Gastrointest Liver Physiol, January 1, 2009; 296(1): G112 - G118. [Abstract] [Full Text] [PDF]

				M. D. Buzzelli, M. Nagarajan, J. F. Radtka, M. L. Shumate, M. Navaratnarajah, C. H. Lang, and R. N. Cooney Nuclear Factor-{kappa}B Mediates the Inhibitory Effects of Tumor Necrosis Factor-{alpha} on Growth Hormone-Inducible Gene Expression in Liver Endocrinology, December 1, 2008; 149(12): 6378 - 6388. [Abstract] [Full Text] [PDF]

				R. Matsushima-Nishiwaki, S. Takai, S. Adachi, C. Minamitani, E. Yasuda, T. Noda, K. Kato, H. Toyoda, Y. Kaneoka, A. Yamaguchi, et al. Phosphorylated Heat Shock Protein 27 Represses Growth of Hepatocellular Carcinoma via Inhibition of Extracellular Signal-regulated Kinase J. Biol. Chem., July 4, 2008; 283(27): 18852 - 18860. [Abstract] [Full Text] [PDF]

				B. L. Moss, S. Gross, S. T. Gammon, A. Vinjamoori, and D. Piwnica-Worms Identification of a Ligand-induced Transient Refractory Period in Nuclear Factor-{kappa}B Signaling J. Biol. Chem., March 28, 2008; 283(13): 8687 - 8698. [Abstract] [Full Text] [PDF]

				R. Goel, B. Boylan, L. Gruman, P. J. Newman, P. E. North, and D. K. Newman The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1205 - G1214. [Abstract] [Full Text] [PDF]

				L. Faulkner, D. M. Altmann, S. Ellmerich, I. Huhtaniemi, G. Stamp, and S. Sriskandan Sexual Dimorphism in Superantigen Shock Involves Elevated TNF-{alpha} and TNF-{alpha} induced Hepatic Apoptosis Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 473 - 482. [Abstract] [Full Text] [PDF]